193 related articles for article (PubMed ID: 30531474)
1. Citrate therapy for calcium phosphate stones.
Rimer JD; Sakhaee K; Maalouf NM
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):130-139. PubMed ID: 30531474
[TBL] [Abstract][Full Text] [Related]
2. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
4. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
Doizi S; Poindexter JR; Pearle MS; Blanco F; Moe OW; Sakhaee K; Maalouf NM
J Urol; 2018 Dec; 200(6):1278-1284. PubMed ID: 30036516
[TBL] [Abstract][Full Text] [Related]
5. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
Robertson WG
Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
[TBL] [Abstract][Full Text] [Related]
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
7. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
8. Evidence for disordered acid-base handling in calcium stone-forming patients.
Worcester EM; Bergsland KJ; Gillen DL; Coe FL
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
[TBL] [Abstract][Full Text] [Related]
9. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
10. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
11. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate.
Pak CY; Rodgers K; Poindexter JR; Sakhaee K
J Urol; 2008 Oct; 180(4):1532-7. PubMed ID: 18710766
[TBL] [Abstract][Full Text] [Related]
12. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
13. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
14. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
Parks JH; Coe FL; Evan AP; Worcester EM
Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
[TBL] [Abstract][Full Text] [Related]
15. Influence of urine pH and citrate concentration on the upper limit of metastability for calcium phosphate.
Greischar A; Nakagawa Y; Coe FL
J Urol; 2003 Mar; 169(3):867-70. PubMed ID: 12576801
[TBL] [Abstract][Full Text] [Related]
16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
[TBL] [Abstract][Full Text] [Related]
18. Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?
Siener R
Urolithiasis; 2016 Feb; 44(1):51-6. PubMed ID: 26614113
[TBL] [Abstract][Full Text] [Related]
19. Urine citrate and renal stone disease.
Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology-based treatment of idiopathic calcium kidney stones.
Coe FL; Evan A; Worcester E
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2083-92. PubMed ID: 21825103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
